Alps Advisors Inc Immunocore Holdings PLC Transaction History

Alps Advisors Inc

  • $17.2 Billion
  • Q1 2025

A detailed history of Alps Advisors Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Alps Advisors Inc holds 35,836 shares of IMCR stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,836
Previous 40,454 11.42%
Holding current value
$1.29 Million
Previous $1.19 Million 10.9%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 30, 2025
SELL
$28.21 - $33.0 $130,273 - $152,394
-4,618 Reduced 11.42%
35,836 $1.06 Million
Q4 2024

Feb 13, 2025
BUY
$28.14 - $34.69 $59,206 - $72,987
2,104 Added 5.49%
40,454 $1.19 Million
Q3 2024

Nov 12, 2024
BUY
$30.06 - $41.49 $8,717 - $12,032
290 Added 0.76%
38,350 $1.19 Million
Q2 2024

Aug 13, 2024
BUY
$33.78 - $63.75 $98,806 - $186,468
2,925 Added 8.33%
38,060 $1.29 Million
Q1 2024

May 14, 2024
BUY
$60.14 - $75.36 $104,944 - $131,503
1,745 Added 5.23%
35,135 $2.28 Million
Q4 2023

Feb 14, 2024
SELL
$42.85 - $69.5 $119,037 - $193,071
-2,778 Reduced 7.68%
33,390 $2.28 Million
Q3 2023

Nov 14, 2023
SELL
$49.5 - $66.6 $48,856 - $65,734
-987 Reduced 2.66%
36,168 $1.88 Million
Q2 2023

Aug 14, 2023
BUY
$48.54 - $61.64 $265,805 - $337,540
5,476 Added 17.29%
37,155 $2.23 Million
Q1 2023

May 10, 2023
BUY
$46.12 - $65.71 $45,382 - $64,658
984 Added 3.21%
31,679 $1.57 Million
Q4 2022

Feb 14, 2023
BUY
$45.51 - $65.08 $306,600 - $438,443
6,737 Added 28.12%
30,695 $1.75 Million
Q3 2022

Nov 14, 2022
SELL
$37.34 - $57.44 $58,549 - $90,065
-1,568 Reduced 6.14%
23,958 $1.13 Million
Q2 2022

Aug 11, 2022
SELL
$25.46 - $37.72 $476,102 - $705,364
-18,700 Reduced 42.28%
25,526 $952,000
Q1 2022

May 16, 2022
SELL
$18.94 - $34.29 $122,049 - $220,964
-6,444 Reduced 12.72%
44,226 $1.32 Million
Q4 2021

Feb 09, 2022
SELL
$27.58 - $40.0 $82,546 - $119,720
-2,993 Reduced 5.58%
50,670 $1.74 Million
Q3 2021

Nov 15, 2021
SELL
$27.98 - $40.0 $101,007 - $144,400
-3,610 Reduced 6.3%
53,663 $1.99 Million
Q2 2021

Aug 11, 2021
BUY
$32.22 - $41.5 $1.85 Million - $2.38 Million
57,273 New
57,273 $2.24 Million

Others Institutions Holding IMCR

# of Institutions
128
Shares Held
44.6M
Call Options Held
219K
Put Options Held
125K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.58B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email